Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cells.

Add to Collection

2011 Sep 4 Others HL Trivedi, UG Thakkar, AV Vanikar, SD Dave - Case Reports, 2011 - casereports.bmj.com 21

Full Author : ['Trivedi, Hargovind L', 'Thakkar, Umang G', 'Vanikar, Aruna V', 'Dave, Shruti D']
Journal Title : BMJ case reports
Chapter : Section18, Section2, Section4
Journal Year : 2011
Cited by : 8

The authors report a 17-year-female and a 19-year-male with uncontrolled insulin-dependent diabetes mellitus (IDDM) for >/=10 years, treated with insulin-secreting human adipose tissue derived mesenchymal stem cells (IS-h-ADMSC). Both had hypothyroidism a..... Read More

Keywords : ['polyglandular autoimmune syndrome type use cotransplantation', 'insulinsecrete mesenchymal stem cell', 'haematopoietic stem cell', 'treatment']
PubMed Link : https://casereports.bmj.com/content/2011/bcr.07.2011.4436.short
Google Scholar Link : https://scholar.google.com/scholar?cites=13918683932252570388&as_sdt=40005&sciodt=0,10&hl=en&num=20

Have a Question?

Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cells.